These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 22286090)
1. In vitro activities of the novel ceragenin CSA-13, alone or in combination with colistin, tobramycin, and ciprofloxacin, against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients. Bozkurt-Guzel C; Savage PB; Gerceker AA Chemotherapy; 2011; 57(6):505-10. PubMed ID: 22286090 [TBL] [Abstract][Full Text] [Related]
2. In vitro activities of various antibiotics, alone and in combination with colistin methanesulfonate, against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients. Güzel CB; Gerçeker AA Chemotherapy; 2008; 54(2):147-51. PubMed ID: 18322363 [TBL] [Abstract][Full Text] [Related]
3. Potential synergy activity of the novel ceragenin, CSA-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa. Chin JN; Jones RN; Sader HS; Savage PB; Rybak MJ J Antimicrob Chemother; 2008 Feb; 61(2):365-70. PubMed ID: 18079128 [TBL] [Abstract][Full Text] [Related]
4. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562 [TBL] [Abstract][Full Text] [Related]
5. Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols. Taccetti G; Bianchini E; Cariani L; Buzzetti R; Costantini D; Trevisan F; Zavataro L; Campana S; Thorax; 2012 Oct; 67(10):853-9. PubMed ID: 22379071 [TBL] [Abstract][Full Text] [Related]
6. Potential synergy activity of the novel ceragenin, CSA-13, against carbapenem-resistant Acinetobacter baumannii strains isolated from bacteremia patients. Bozkurt-Guzel C; Savage PB; Akcali A; Ozbek-Celik B Biomed Res Int; 2014; 2014():710273. PubMed ID: 24804236 [TBL] [Abstract][Full Text] [Related]
7. [In vitro bactericidal activity of tobramycin and amikacin alone or in combination against Pseudomonas aeruginosa isolated from patients with cystic fibrosis]. Bertrou A; Marty N; Henry S; Agueda L; Chabanon G Pathol Biol (Paris); 1990 May; 38(5):366-75. PubMed ID: 2114606 [TBL] [Abstract][Full Text] [Related]
8. Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa. Herrmann G; Yang L; Wu H; Song Z; Wang H; Høiby N; Ulrich M; Molin S; Riethmüller J; Döring G J Infect Dis; 2010 Nov; 202(10):1585-92. PubMed ID: 20942647 [TBL] [Abstract][Full Text] [Related]
9. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience. Hansen CR; Pressler T; Høiby N J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions. McCaughey G; McKevitt M; Elborn JS; Tunney MM J Cyst Fibros; 2012 May; 11(3):163-72. PubMed ID: 22138067 [TBL] [Abstract][Full Text] [Related]
11. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions. Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967 [TBL] [Abstract][Full Text] [Related]
12. CSA-131, a ceragenin active against colistin-resistant Acinetobacter baumannii and Pseudomonas aeruginosa clinical isolates. Vila-Farrés X; Callarisa AE; Gu X; Savage PB; Giralt E; Vila J Int J Antimicrob Agents; 2015 Nov; 46(5):568-71. PubMed ID: 26395218 [TBL] [Abstract][Full Text] [Related]
13. Interaction between tobramycin and CSA-13 on clinical isolates of Pseudomonas aeruginosa in a model of young and mature biofilms. Nagant C; Tré-Hardy M; El-Ouaaliti M; Savage P; Devleeschouwer M; Dehaye JP Appl Microbiol Biotechnol; 2010 Sep; 88(1):251-63. PubMed ID: 20625718 [TBL] [Abstract][Full Text] [Related]
14. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with multiresistant strains of Pseudomonas aeruginosa. Lang BJ; Aaron SD; Ferris W; Hebert PC; MacDonald NE Am J Respir Crit Care Med; 2000 Dec; 162(6):2241-5. PubMed ID: 11112146 [TBL] [Abstract][Full Text] [Related]
15. In vitro activities of nisin alone or in combination with vancomycin and ciprofloxacin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains. Dosler S; Gerceker AA Chemotherapy; 2011; 57(6):511-6. PubMed ID: 22302084 [TBL] [Abstract][Full Text] [Related]
16. Resistance to tobramycin and colistin in isolates of Pseudomonas aeruginosa from chronically colonized patients with cystic fibrosis under antimicrobial treatment. Valenza G; Radike K; Schoen C; Horn S; Oesterlein A; Frosch M; Abele-Horn M; Hebestreit H Scand J Infect Dis; 2010 Dec; 42(11-12):885-9. PubMed ID: 20735333 [TBL] [Abstract][Full Text] [Related]
17. Post-antibiotic effect of levofloxacin and tobramycin alone or in combination with cefepime against Pseudomonas aeruginosa. Ozbek B; Otuk G Chemotherapy; 2009; 55(6):446-50. PubMed ID: 19996590 [TBL] [Abstract][Full Text] [Related]
18. [Combined application of ciprofloxacin and tobramycin on mutant selective windows of ciprofloxacin against Pseudomonas aeruginosa]. Liu MT; Sheng MY; Zhang Y; Li Y Zhonghua Yi Xue Za Zhi; 2011 May; 91(20):1427-31. PubMed ID: 21756818 [TBL] [Abstract][Full Text] [Related]
19. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients. Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E; Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983 [TBL] [Abstract][Full Text] [Related]
20. Development of a rapid colorimetric time-kill assay for determining the in vitro activity of ceftazidime and tobramycin in combination against Pseudomonas aeruginosa. Moriarty F; Elborn S; Tunney M J Microbiol Methods; 2005 May; 61(2):171-9. PubMed ID: 15722142 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]